| Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection CP Minniti, AU Zaidi, M Nouraie, D Manwani, GD Crouch, AS Crouch, ... Blood advances 5 (1), 207-215, 2021 | 70 | 2021 |
| Pulmonary embolism in children AU Zaidi, KK Hutchins, M Rajpurkar Frontiers in pediatrics 5, 170, 2017 | 67 | 2017 |
| Evaluation of Longitudinal Pain Study in Sickle Cell Disease (ELIPSIS) by patient-reported outcomes, actigraphy, and biomarkers DD Pittman, PC Hines, D Beidler, D Rybin, AL Frelinger III, AD Michelson, ... Blood, The Journal of the American Society of Hematology 137 (15), 2010-2020, 2021 | 29 | 2021 |
| Acute vaso-occlusive pain is temporally associated with the onset of menstruation in women with sickle cell disease D Sharma, ME Day, SJ Stimpson, M Rodeghier, D Ghafuri, M Callaghan, ... Journal of Women's Health 28 (2), 162-169, 2019 | 23 | 2019 |
| A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease AU Zaidi, AK Glaros, S Lee, T Wang, R Bhojwani, E Morris, B Donohue, ... Orphanet journal of rare diseases 16, 1-12, 2021 | 21 | 2021 |
| Voxelotor: alteration of sickle cell disease pathophysiology by a first-in-class polymerization inhibitor AK Glaros, R Razvi, N Shah, AU Zaidi Therapeutic advances in hematology 12, 20406207211001136, 2021 | 18 | 2021 |
| Clinical diagnosis of red cell membrane disorders: comparison of osmotic gradient Ektacytometry and eosin Maleimide (EMA) fluorescence test for red cell band 3 (AE1, SLC4A1 … AU Zaidi, S Buck, M Gadgeel, M Herrera-Martinez, A Mohan, K Johnson, ... Frontiers in Physiology 11, 636, 2020 | 17 | 2020 |
| Mild erythrocytosis as a presenting manifestation of PIEZO1 associated erythrocyte volume disorders T Knight, AU Zaidi, S Wu, M Gadgeel, S Buck, Y Ravindranath Pediatric Hematology and Oncology 36 (5), 317-326, 2019 | 15 | 2019 |
| Contraceptive Methods and the Impact of Menstruation on Daily Functioning in Women with Sickle Cell Disease. ME Day, SJ Stimpson, M Rodeghier, D Ghafuri, M Callaghan, AU Zaidi, ... Southern Medical Journal 112 (3), 174-179, 2019 | 12 | 2019 |
| A reanalysis of pain crises data from the pivotal l-glutamine in sickle cell disease trial AU Zaidi, J Estepp, N Shah, S Alkindi, H Ezzat, H Lam, CP Minniti Contemporary Clinical Trials 110, 106546, 2021 | 11 | 2021 |
| Flow adhesion of whole blood to P‐selectin: a prognostic biomarker for vaso‐occlusive crisis in sickle cell disease PC Hines, MU Callaghan, AU Zaidi, X Gao, K Liu, J White, M Tarasev British journal of haematology 194 (6), 1074-1082, 2021 | 10 | 2021 |
| Glucose phosphate isomerase (GPI) Tadikonda: characterization of a novel Pro340Ser mutation AU Zaidi, P Kedar, PR Koduri, GW Goyette Jr, S Buck, DE Paglia, ... Pediatric Hematology and Oncology 34 (8), 449-454, 2017 | 9 | 2017 |
| Distinctive phenotypes in two children with novel germline RUNX1 mutations - one with myeloid malignancy and increased fetal hemoglobin S Bagla, KA Regling, EN Wakeling, M Gadgeel, S Buck, AU Zaidi, ... Pediatric Hematology and Oncology 38 (1), 65-79, 2020 | 8 | 2020 |
| Crossing the Thrombotic Threshold: Deep Vein Thrombosis in Henoch–Schönlein Purpura AU Zaidi, B Berman Clinical Pediatrics 53 (14), 1396-1398, 2014 | 8 | 2014 |
| Tweetopoiesis: a peripheral review of twitter for hematologists AC Weyand, AU Zaidi John Wiley & Sons, Inc., 2021 | 6 | 2021 |
| Real-world effectiveness of voxelotor for treating sickle cell disease in the US AU Zaidi, T Lipato, OA Alvarez, A Lonshteyn, D Weycker, N Pham, ... Blood 136, 25, 2020 | 6 | 2020 |
| Longitudinal assessment of adhesion to vascular cell adhesion molecule‐1 at steady state and during vaso‐occlusive crises in sickle cell disease J White, MU Callaghan, X Gao, K Liu, A Zaidi, M Tarasev, PC Hines British Journal of Haematology 196 (4), 1052-1058, 2022 | 5 | 2022 |
| Navigating a new terrain: how Twitter is changing hematologists AU Zaidi, AK Glaros, AC Weyand Blood Advances 5 (1), 277-278, 2021 | 5 | 2021 |
| Identification of a novel variant in phosphoglycerate kinase-1 (PGK1) in an African-American child (PGK1 Detroit) AU Zaidi, S Bagla, Y Ravindranath Pediatric Hematology and Oncology 36 (5), 302-308, 2019 | 5 | 2019 |
| A phase 2/3, randomized, double-blind, placebo-controlled study of mitapivat in patients with sickle cell disease J Howard, KHM Kuo, A Oluyadi, H Shao, S Morris, AU Zaidi, EJ Van Beers, ... Blood 138, 3109, 2021 | 4 | 2021 |
Michael Urban CallaghanAssociate Professor of Pediatrics, Central Michigan UniversityVerified email at cmich.edu
